Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 14Prostatic Neoplasms 3Neoplasm Metastasis 3Carcinoma, Non-Small-Cell Lung 3Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Stomach Neoplasms 1Skin Neoplasms 1Sarcoma 1Prostatic Diseases 1Overweight 1Obesity 1Neoplasms by Site 1Neoplasms 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Histiocytoma, Malignant Fibrous 1Genital Neoplasms, Male 1Disease 1Carcinoma, Signet Ring Cell 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1

Interventions

Oxaliplatin 1Nivolumab 1Leucovorin 1Fluorouracil 1Biopsy, Needle 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Signet Ring Cell × Biopsy, Needle × Clear all
NCT02594943 2018-11-26

Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer

Region Skane

Phase NA Withdrawn
Gastrointestinal

Stomach Neoplasms, Carcinoma, Signet Ring Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡